How USA TODAY rates MEDVi for weight loss The USA TODAY team ranks and reviews online GLP-1 weight loss platforms
The prescribing clinician can assess whether the reaction is likely related to Ozempic, consider alternative diagnoses (such as eczema, contact dermatitis, or unrelated skin conditions), and determine whether dose adjustment or discontinuation is necessary
They work in different ways to control appetite and promote satiety
Regulators, pharmacists, and healthcare providers are alarmed by the trend, reported in the New York Times , because Ozempic maker Novo Nordisk doesn't sell the drug for compounding, and there is no Food and Drug Administration (FDA)-approved generic version
To illustrate this, lets take a look at a clinical trial that compared weight loss with Wegovy vs Mounjaro over 72 weeks (18 months)